Contact Us: 01282 426380
KM Financial Solutions | Amgen to buy Celgene’s psoriasis drug Otezla for $13.4 bln in cash
49625
post-template-default,single,single-post,postid-49625,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Amgen to buy Celgene’s psoriasis drug Otezla for $13.4 bln in cash

25 Aug Amgen to buy Celgene’s psoriasis drug Otezla for $13.4 bln in cash

Posted at 10:43h in News by
0 Likes
Amgen Inc said on Monday it would
buy Celgene Corp’s psoriasis drug Otezla for $13.4
billion in cash, clearing the way for Bristol-Myers Squibb
to go ahead with its $74 billion deal for Celgene.

No Comments

Sorry, the comment form is closed at this time.